“13. 14:14 “First one- We can simply add more patients to the Open-Label of CD12 that we have, and recalculate the p-value until it is less than .05. Is this acceptable by regulatory agencies?”

Is it acceptable to continue on this path without knowing if it is acceptable to regulatory agencies? I think it is clear that it is not acceptable to US FDA. I believe NP's hope is that the Philippine FDA might accept it. Hope is a poor strategy at this late stage.